Gilman Hill Asset Management, LLC Biolife Solutions Inc Transaction History

Gilman Hill Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$42.03 - $60.5 $210,150 - $302,500	-5,000 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$29.51 - $44.62 $147,550 - $223,100	5,000 New	5,000 $223,000
Q1 2021 Apr 19, 2021	SELL	$32.95 - $44.24 $218,293 - $293,090	-6,625 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$27.5 - $45.75 $92,812 - $154,406	-3,375 Reduced 33.75%	6,625 $264,000
Q2 2020 Jul 20, 2020	SELL	$9.2 - $17.06 $23,000 - $42,650	-2,500 Reduced 20.0%	10,000 $164,000
Q1 2020 Apr 22, 2020	BUY	$8.36 - $17.03 $104,500 - $212,875	12,500 New	12,500 $119,000

198

44.9M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.13B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.